Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.75% | 24.52% | 32.54% | 29.65% | 28.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.75% | 24.52% | 32.54% | 29.65% | 28.24% |
| Cost of Revenue | 24.04% | 28.28% | 32.88% | 23.05% | 24.48% |
| Gross Profit | 22.52% | 23.88% | 32.48% | 30.91% | 28.93% |
| SG&A Expenses | 14.86% | 14.02% | 15.14% | 17.28% | 23.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.15% | 13.44% | 13.25% | 13.77% | 21.60% |
| Operating Income | 90.24% | 242.95% | 206.29% | 130.72% | 21.95% |
| Income Before Tax | 144.46% | 140.39% | 347.88% | 192.40% | 38.49% |
| Income Tax Expenses | 79.54% | 196.02% | 437.94% | 392.06% | 200.93% |
| Earnings from Continuing Operations | 129.91% | 138.60% | 316.59% | 181.94% | 35.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 129.91% | 138.60% | 316.59% | 181.94% | 35.13% |
| EBIT | 90.24% | 242.95% | 206.29% | 130.72% | 21.95% |
| EBITDA | 110.84% | 239.75% | 227.37% | 140.66% | 23.94% |
| EPS Basic | 129.81% | 136.13% | 312.90% | 180.56% | 36.29% |
| Normalized Basic EPS | 144.33% | 137.90% | 343.67% | 190.84% | 39.58% |
| EPS Diluted | 129.41% | 132.40% | 306.33% | 178.05% | 35.87% |
| Normalized Diluted EPS | 143.47% | 136.38% | 337.65% | 188.80% | 39.58% |
| Average Basic Shares Outstanding | 0.29% | 1.05% | 1.75% | 1.71% | 1.81% |
| Average Diluted Shares Outstanding | 2.35% | 1.70% | 4.32% | 4.03% | 1.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |